Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matilde Cacciatore

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Pathologica|July 23, 2021
CholangiocarcinomaSamantha Sarcognato, Diana Sacchi, Matteo Fassan, et al.
Cell and Tissue Banking|January 25, 2023
Decellularized cryopreserved human pericardium: a validation study towards tissue bank practiceGiulia Montagner, Antonia Barbazza, Andrea Tancredi Lugas, et al.
Human Pathology|May 24, 2015
Broadening the spectrum of SMARCB1-associated malignant tumors: a case of uterine leiomyosarcoma in a patient with schwannomatosisIrene Paganini, Roberta Sestini, Matilde Cacciatore, et al.
JCI Insight|October 13, 2020
Tumor genotype, location, and malignant potential shape the immunogenicity of primary untreated gastrointestinal stromal tumorsDaniela Gasparotto, Marta Sbaraglia, Sabrina Rossi, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 14, 2018
Proinsulin-expressing dendritic cells in type 2 neuropathic diabetic patients with and without foot lesionsMaria Sambataro, Luisa Sambado, Enrica Trevisiol, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 2, 2017
Neurofibromin C terminus-specific antibody (clone NFC) is a valuable tool for the identification of NF1-inactivated GISTsSabrina Rossi, Daniela Gasparotto, Matilde Cacciatore, et al.
NPJ Breast Cancer|October 13, 2021
Evolution of HER2-low expression from primary to recurrent breast cancerFederica Miglietta, Gaia Griguolo, Michele Bottosso, et al.
NPJ Breast Cancer|November 25, 2021
Author Correction: Evolution of HER2-low expression from primary to recurrent breast cancerFederica Miglietta, Gaia Griguolo, Michele Bottosso, et al.
NPJ Breast Cancer|May 20, 2022
HER2-low-positive breast cancer: evolution from primary tumor to residual disease after neoadjuvant treatmentFederica Miglietta, Gaia Griguolo, Michele Bottosso, et al.
Molecular Oncology|April 22, 2014
PDGFRβ and FGFR2 mediate endothelial cell differentiation capability of triple negative breast carcinoma cellsIlaria Plantamura, Patrizia Casalini, Erica Dugnani, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Pathologica|July 23, 2021
CholangiocarcinomaSamantha Sarcognato, Diana Sacchi, Matteo Fassan, et al.
Cell and Tissue Banking|January 25, 2023
Decellularized cryopreserved human pericardium: a validation study towards tissue bank practiceGiulia Montagner, Antonia Barbazza, Andrea Tancredi Lugas, et al.
Human Pathology|May 24, 2015
Broadening the spectrum of SMARCB1-associated malignant tumors: a case of uterine leiomyosarcoma in a patient with schwannomatosisIrene Paganini, Roberta Sestini, Matilde Cacciatore, et al.
JCI Insight|October 13, 2020
Tumor genotype, location, and malignant potential shape the immunogenicity of primary untreated gastrointestinal stromal tumorsDaniela Gasparotto, Marta Sbaraglia, Sabrina Rossi, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 14, 2018
Proinsulin-expressing dendritic cells in type 2 neuropathic diabetic patients with and without foot lesionsMaria Sambataro, Luisa Sambado, Enrica Trevisiol, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 2, 2017
Neurofibromin C terminus-specific antibody (clone NFC) is a valuable tool for the identification of NF1-inactivated GISTsSabrina Rossi, Daniela Gasparotto, Matilde Cacciatore, et al.
NPJ Breast Cancer|October 13, 2021
Evolution of HER2-low expression from primary to recurrent breast cancerFederica Miglietta, Gaia Griguolo, Michele Bottosso, et al.
NPJ Breast Cancer|November 25, 2021
Author Correction: Evolution of HER2-low expression from primary to recurrent breast cancerFederica Miglietta, Gaia Griguolo, Michele Bottosso, et al.
NPJ Breast Cancer|May 20, 2022
HER2-low-positive breast cancer: evolution from primary tumor to residual disease after neoadjuvant treatmentFederica Miglietta, Gaia Griguolo, Michele Bottosso, et al.
Molecular Oncology|April 22, 2014
PDGFRβ and FGFR2 mediate endothelial cell differentiation capability of triple negative breast carcinoma cellsIlaria Plantamura, Patrizia Casalini, Erica Dugnani, et al.
Pageof 3